Taming glioblastoma by targeting angiogenesis: 3 years later.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Vagus nerve stimulation: Novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the SASP, enhancing tumor immunity.Brain, behavior, & immunity - health · 2024
   Review
2. The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials.Frontiers in oncology · 2024
   Review
3. Subtraction Maps Derived from Longitudinal Magnetic Resonance Imaging in Patients with Glioma Facilitate Early Detection of Tumor Progression.Cancers · 2020
   Article
4. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies.Histology and histopathology · 2017
   Article
5. Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues.Proceedings of the National Academy of Sciences of the United States of America · 2013
   Article
6. Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.Neuro-oncology · 2012
   Review
7. State of the art and perspectives in the treatment of glioblastoma.CNS oncology · 2012
   Review
8. Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma.Histology and histopathology · 2012
   Review
9. Antiangiogenic therapy for patients with recurrent and newly diagnosed malignant gliomas.Journal of oncology · 2012
   Article
10. Normalization of the vasculature for treatment of cancer and other diseases.Physiological reviews · 2011
    Review

Corrections and comments

• Comment on
  Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as